(Q40305890)

English

Phase II multicenter, randomized, double-blind study of recombinant mutated human tumor necrosis factor-α in combination with chemotherapies in cancer patients

scientific article published on 9 January 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Phase II multicenter, randomized, double-blind study of recombinant mutated human tumor necrosis factor-α in combination with chemotherapies in cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

multicenter clinical trial

0 references

author name string

Meng Li

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Tianjiao Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Zhao Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Xiaochang Xue

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Xiaochang Xue

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Cun Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Xin Qin

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Weina Li

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Qiang Hao

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Wei Zhang

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yingqi Zhang

11

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

9 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

288-295

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

TNF: a moonlighting protein at the interface between cancer and infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

The TNF and TNF receptor superfamilies: integrating mammalian biology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

The pathophysiologic role of cachectin/TNF in septic shock and cachexia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

Microvascular dysfunction and skeletal muscle oxygenation assessed by phase-modulation near-infrared spectroscopy in patients with septic shock

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surface

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

A mutated human tumor necrosis factor-alpha improves the therapeutic index in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

Safety evaluation and pharmacokinetics of a novel human tumor necrosis factor-alpha exhibited a higher antitumor activity and a lower systemic toxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

TNF and manipulation of the tumor cell-stromal interface: "ways to make chemotherapy effective".

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

The Role of the Microtubules in Tumor Necrosis Factor-α–Induced Endothelial Cell Permeability

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

Coley's toxins in perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02153.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2011.02153.X

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40305890&oldid=1894226475"